The issuance of securities in connection with this Offering will be subject to Canadian Securities Exchange approval and the securities will be subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable Canadian securities laws.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN

The Offering is subject to customary closing conditions including, but not limited to, receipt of approval of the TSX Venture Exchange (the " TSX-V "). The closing of the Offering may occur in one or more tranches, and is not subject to receipt of a minimum amount of gross proceeds.

The expiry date of the Warrants may be accelerated by Inventus if the closing price of the Common Shares on the TSX Venture Exchange (the “TSXV”) is greater than or equal to $0.12 over a consecutive 20-day period.

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the private placement of common shares at $21.